Exai Bio
exai.bioLocations
Palo Alto, CA, USA
industry
Biotechnology · DeepTech · Health
Size
51-200 employees
Stage
Series A
founded in
2021
Exai Bio is a next-generation liquid biopsy company that utilizes proprietary RNA biomarkers and artificial intelligence to provide actionable insights into cancer biology from a simple blood draw. Their innovative platform aims to revolutionize cancer diagnosis, treatment, and management by delivering early and accurate detection of cancer, setting them apart in the market. With a focus on novel RNA technology, Exai Bio is positioned to make significant advancements in the field of oncology, leveraging their unique approach to improve patient outcomes.
Something looks off?Open jobs at Exai Bio
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.